Skip to main content
. 2023 Mar 15;7(13):3080–3086. doi: 10.1182/bloodadvances.2022009147

Table 6.

Percentages of absence of SCR at follow-up

No SCR at end of follow-up, n/total (%) P value
HbSS/HbSβ0/HbSβ+ 51 of 83 (61.4) .025
 Male 19 of 39 (48.7)
 Female 32 of 44 (72.7)
HbSC 14 of 46 (30.4) .177
 Male 4 of 20 (20)
 Female 10 of 26 (38.5)

Pearson χ2.